A Multicenter, Open-Label, Flexible-Dose, Parallel-Group Evaluation of the Cataractogenic Potential of Study Drug and Study Drug in the Long-Term Treatment of Patients with Schizophrenia or Schizoaffective Disorder

Efficacy and Safety of Study Drug in Patients with Borderline Personality Disorder: A Randomized Double Blind Comparison with Placebo

An Analysis of Mortality in Subjects who Participated in Three Studies of Study Drug in Mild Cognitive Impairment

A Comparison of Study Drug Dosing Strategies in the Treatment of Patients with Major Depression

An Assessment of Behavioral Changes Associated with Study Drug and Study Drug in Patients with Epilepsy

An International, Multicenter, Large Simple Trial to Compare the Cardiovascular Safety of Study Drug and Study Drug (Schizophrenia)

A Multicenter, Double-Blind, Flexible-Dose, 6-Month Trial Comparing the Efficacy and Safety of Study Drug with Study Drug in Stable Subjects with Predominant, Persistent Negative Symptoms of Schizophrenia